Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2021-07-28 2021-05-27
Drug Identification Number 02184435 02184435
Brand name KADIAN KADIAN
Common or Proper name MORPHINE SULFATE MORPHINE SULFATE
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients MORPHINE SULFATE MORPHINE SULFATE
Strength(s) 20MG 20MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT 100BT
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-07-21 2021-07-21
Actual start date 2021-06-23
Estimated end date 2021-08-24 2021-08-24
Actual end date 2021-07-26
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments